V
Vernon K. Sondak
Researcher at University of South Florida
Publications - 507
Citations - 30734
Vernon K. Sondak is an academic researcher from University of South Florida. The author has contributed to research in topics: Melanoma & Sentinel lymph node. The author has an hindex of 72, co-authored 475 publications receiving 27401 citations. Previous affiliations of Vernon K. Sondak include University of Oxford & Nevada Cancer Institute.
Papers
More filters
Journal ArticleDOI
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch,Jeffrey E. Gershenwald,Seng-Jaw Soong,John F. Thompson,Michael B. Atkins,David R. Byrd,Antonio C. Buzaid,Alistair J. Cochran,Daniel G. Coit,Shouluan Ding,Alexander M.M. Eggermont,Keith T. Flaherty,Phyllis A. Gimotty,John M. Kirkwood,Kelly M. McMasters,Martin C. Mihm,Donald L. Morton,Merrick I. Ross,Arthur J. Sober,Vernon K. Sondak +19 more
TL;DR: Revised melanoma staging system has been made that reflect the improved understanding of this disease and will be formally incorporated into the seventh edition of the AJCC Cancer Staging Manual and implemented by early 2010.
Journal ArticleDOI
Molecular classification of cutaneous malignant melanoma by gene expression profiling
M. Bittner,Paul S. Meltzer,Yi Chen,Yong-hui Jiang,E. A. Seftor,Mary J.C. Hendrix,Michael D. Radmacher,Richard M. Simon,Zohar Yakhini,Amir Ben-Dor,Amir Ben-Dor,Nick Sampas,Edward R. Dougherty,Ena Wang,Francesco M. Marincola,C. Gooden,John Lueders,Arthur A. Glatfelter,P.C.A. Pollock,John D. Carpten,E. Gillanders,D. Leja,K. Dietrich,Christian Beaudry,Michael E. Berens,David S. Alberts,Vernon K. Sondak,Nicholas K. Hayward,J.M. Trent +28 more
TL;DR: Many genes underlying the classification of this subset of melanomas are differentially regulated in invasive melanomas that form primitive tubular networks in vitro, a feature of some highly aggressive metastatic melanomas.
Journal ArticleDOI
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Jeffrey E. Gershenwald,Richard A. Scolyer,Kenneth R. Hess,Vernon K. Sondak,Georgina V. Long,M. I. Ross,Alexander J. Lazar,Mark B. Faries,John M. Kirkwood,Grant A. McArthur,Lauren E. Haydu,Alexander M.M. Eggermont,Keith T. Flaherty,Charles M. Balch,John F. Thompson +14 more
TL;DR: The melanoma staging system of the American Joint Committee on Cancer (AJCC) was updated in 2017 as discussed by the authors, with several important changes to the tumor, nodes, metastasis (TNM) classification and stage grouping criteria.
Journal ArticleDOI
High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801
John M. Kirkwood,Joseph Ibrahim,Jeffrey A. Sosman,Vernon K. Sondak,Sanjiv S. Agarwala,Marc S. Ernstoff,Uma Rao +6 more
TL;DR: A significant treatment benefit of HDI versus GMK in terms of RFS and OS in melanoma patients at high risk of recurrence is demonstrated in this prospective, randomized, intergroup trial.
Journal ArticleDOI
High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190
John M. Kirkwood,Joseph G. Ibrahim,Vernon K. Sondak,Jon M. Richards,Lawrence E. Flaherty,Marc S. Ernstoff,Thomas J. Smith,Uma Rao,Mary Steele,Ronald H. Blum +9 more
TL;DR: The results of the intergroup E1690 trial demonstrate an RFS benefit of IFNalpha2b that is dose-dependent and significant for HDI by Cox multivariable analysis.